- Supply chain disruptions due to unexpected increases in raw material costs and climate-related extreme weather events.
- Water scarcity in regions with limited water resources.
- Risks related to occupational health and safety, discrimination, and unethical behavior.
- Reputational risks due to neglecting the social impact of products and services.
Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. disclosed greenhouse gas emissions of 9.2K tCO2e/year. By scope: Scope 1: 3.7K tCO2e/year; Scope 2: 6.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
9.2K tCO2e/year
2023
Water Usage
83.2K m3/year
2023
Waste
114.2K tons/year
2023
Energy Use
15.2M kWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 3.7K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 6.6K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Achieved a 4% reduction in Scope 2 emissions through the partial commissioning of rooftop solar power plants.
- Commissioned solar power plants with a total installed capacity of 11.88 MW in Yozgat province.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce water consumption by approximately 30% by implementing 5 projects in 2024.
📅 Medium-term
- Achieve 90-100% renewable energy share by commissioning solar power plants by the first half of 2025.
🌱 ESG Focus Areas
EnvironmentalSocialGovernance